• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于患有对侧异时性第二原发性肺癌的老年患者,肺叶下切除比肺叶切除更有益:基于监测、流行病学和最终结果(SEER)数据库的分析

Sublobar resection is more beneficial than lobar resection in elderly patients with contralateral metachronous second primary lung cancer: an analysis based on the SEER database.

作者信息

Li Zhenjie, Wang Zhi, Wang Silin, Wu Longren, Xiong Linmin, Hu Zijian, Ruan Liancheng, Zhu Lingxiao, Luo Shengbai, Wei Yiping, Yu Dongliang

机构信息

Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

出版信息

J Thorac Dis. 2025 Jun 30;17(6):3783-3796. doi: 10.21037/jtd-2024-2247. Epub 2025 Jun 26.

DOI:10.21037/jtd-2024-2247
PMID:40688322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12268642/
Abstract

BACKGROUND

The optimal surgical approach for treating stage I second primary lung cancer (SPLC) in elderly patients with a history of lobar resection remains uncertain. To address this knowledge gap, we conducted a comparative analysis of lobar resection versus sublobar resection outcomes in elderly patients diagnosed with contralateral stage I SPLC, utilizing population-based databases.

METHODS

We identified elderly patients diagnosed with T1-2N0M0 SPLC from the Surveillance, Epidemiology, and End Results (SEER) database (2008-2015) who had undergone prior lobar resection for their first primary lung cancer. To ensure accurate classification of SPLC, we applied the Martini and Melamed criteria, which distinguish multiple primary lung cancers based on histologic and anatomic features. Survival outcomes were compared using Kaplan-Meier analysis and multivariable Cox proportional hazards regression. To mitigate potential confounding factors, we constructed a matched cohort through propensity score matching (PSM), balancing baseline characteristics between the lobar and sublobar resection groups.

RESULTS

A total of 373 patients met the inclusion criteria, comprising 253 in the sublobar resection group and 120 in the lobar resection group. Following PSM, 297 patients were retained for analysis. The analysis revealed that sublobar resection was associated with significantly improved overall survival (OS) compared to lobar resection in elderly patients with contralateral SPLC, with 5-year OS rates of 43.4% versus 34.3% (P=0.03).

CONCLUSIONS

For elderly patients with contralateral SPLC, sublobar resection is better than lobar resection.

摘要

背景

对于有肺叶切除史的老年患者,治疗Ⅰ期第二原发性肺癌(SPLC)的最佳手术方式仍不确定。为填补这一知识空白,我们利用基于人群的数据库,对诊断为对侧Ⅰ期SPLC的老年患者行肺叶切除与肺段切除的结果进行了对比分析。

方法

我们从监测、流行病学和最终结果(SEER)数据库(2008 - 2015年)中识别出诊断为T1 - 2N0M0 SPLC且曾因第一原发性肺癌接受过肺叶切除的老年患者。为确保SPLC的准确分类,我们应用了Martini和Melamed标准,该标准根据组织学和解剖学特征区分多个原发性肺癌。使用Kaplan - Meier分析和多变量Cox比例风险回归比较生存结果。为减轻潜在的混杂因素,我们通过倾向评分匹配(PSM)构建了一个匹配队列,平衡肺叶切除组和肺段切除组之间的基线特征。

结果

共有373例患者符合纳入标准,其中肺段切除组253例,肺叶切除组120例。PSM后,保留297例患者进行分析。分析显示,在对侧SPLC的老年患者中,与肺叶切除相比,肺段切除与显著改善的总生存期(OS)相关,5年OS率分别为43.4%和34.3%(P = 0.03)。

结论

对于对侧SPLC的老年患者,肺段切除优于肺叶切除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/9aa54bd1a10f/jtd-17-06-3783-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/35bf7f7623ae/jtd-17-06-3783-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/355200cc848e/jtd-17-06-3783-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/9aa54bd1a10f/jtd-17-06-3783-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/35bf7f7623ae/jtd-17-06-3783-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/355200cc848e/jtd-17-06-3783-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9636/12268642/9aa54bd1a10f/jtd-17-06-3783-f3.jpg

相似文献

1
Sublobar resection is more beneficial than lobar resection in elderly patients with contralateral metachronous second primary lung cancer: an analysis based on the SEER database.对于患有对侧异时性第二原发性肺癌的老年患者,肺叶下切除比肺叶切除更有益:基于监测、流行病学和最终结果(SEER)数据库的分析
J Thorac Dis. 2025 Jun 30;17(6):3783-3796. doi: 10.21037/jtd-2024-2247. Epub 2025 Jun 26.
2
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non‑small cell lung cancer.对于患有Ia期非小细胞肺癌的八旬及以上老人,肺段切除术并不逊色于肺叶切除术。
Transl Cancer Res. 2025 May 30;14(5):2966-2980. doi: 10.21037/tcr-2024-2575. Epub 2025 May 14.
3
The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: results from CALGB 140503 (Alliance).肺叶或肺段切除术后淋巴结清扫范围与无病生存期无关:CALGB 140503(联盟)研究结果
J Thorac Cardiovasc Surg. 2025 Jun 16. doi: 10.1016/j.jtcvs.2025.06.007.
4
Comparison of patient-reported outcome measures (PROMs) after thoracoscopic lobar and sublobar resections for non-small cell lung cancer.非小细胞肺癌胸腔镜肺叶和肺段切除术后患者报告结局量表(PROMs)的比较
J Thorac Dis. 2025 Jun 30;17(6):3727-3736. doi: 10.21037/jtd-2025-173. Epub 2025 Jun 19.
5
A Study on the Selection of Surgical Methods for ≤2cm Lung Adenocarcinomas Based on High-resolution CT Features Combined with Solid Component Size on MPVR.基于高分辨率CT特征联合多平面容积再现技术上实性成分大小对≤2cm肺腺癌手术方法选择的研究
Acad Radiol. 2025 Jun 30. doi: 10.1016/j.acra.2025.06.011.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.肺段或亚肺叶切除术治疗外周型ⅠA 期非小细胞肺癌。
N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.≤35岁的IA期非小细胞肺癌患者行肺叶下切除与肺叶切除的比较:一项监测、流行病学和最终结果(SEER)数据库分析
J Cancer Res Clin Oncol. 2017 Nov;143(11):2375-2382. doi: 10.1007/s00432-017-2499-y. Epub 2017 Aug 17.
10
Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.大小≤3cm 的早期第二原发性肺癌行肺叶或亚肺叶切除术:一项 SEER 基于人群的研究。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16679-16690. doi: 10.1007/s00432-023-05396-5. Epub 2023 Sep 19.

本文引用的文献

1
Second Primary Lung Cancer - An Emerging Issue in Lung Cancer Survivors.第二原发性肺癌——肺癌幸存者面临的新问题。
J Thorac Oncol. 2024 Oct;19(10):1415-1426. doi: 10.1016/j.jtho.2024.07.014. Epub 2024 Jul 24.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
解剖性肺段切除术与肺叶切除术后的肺功能恢复及移位模式
Ann Thorac Surg. 2024 Aug;118(2):365-374. doi: 10.1016/j.athoracsur.2024.01.022. Epub 2024 Feb 1.
4
Rapid Advances in Resectable Non-Small Cell Lung Cancer: A Narrative Review.可切除非小细胞肺癌的快速进展:叙述性综述。
JAMA Oncol. 2024 Feb 1;10(2):249-255. doi: 10.1001/jamaoncol.2023.5276.
5
Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.大小≤3cm 的早期第二原发性肺癌行肺叶或亚肺叶切除术:一项 SEER 基于人群的研究。
J Cancer Res Clin Oncol. 2023 Dec;149(18):16679-16690. doi: 10.1007/s00432-023-05396-5. Epub 2023 Sep 19.
6
Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study.术后放疗可能是第二原发性肺癌的一个危险因素:一项基于人群的研究。
Front Oncol. 2022 Oct 6;12:918137. doi: 10.3389/fonc.2022.918137. eCollection 2022.
7
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes.简短报告:对侧肺叶切除术治疗第二原发性非小细胞肺癌:围手术期及长期结果
JTO Clin Res Rep. 2022 Jun 18;3(8):100362. doi: 10.1016/j.jtocrr.2022.100362. eCollection 2022 Aug.
8
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer.早期非小细胞肺癌的新辅助和辅助全身治疗。
Drugs. 2022 Jun;82(8):855-863. doi: 10.1007/s40265-022-01721-3. Epub 2022 May 21.
9
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.小型周围型非小细胞肺癌的肺段切除术与肺叶切除术比较(JCOG0802/WJOG4607L):一项多中心、开放标签、3期、随机、对照、非劣效性试验
Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3.
10
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.美国非小细胞肺癌患者的发病率、患病率、生存率和初始治疗的更新。
JAMA Oncol. 2021 Dec 1;7(12):1824-1832. doi: 10.1001/jamaoncol.2021.4932.